ChemGenex targets NDA for OMAPRO
09 September, 2009 by Tim DeanNew drug application for targeted anti-leukaemia drug completed, mid-2010 launch expected.
QRxPharma pilot study gives good results for MoxDuo
25 August, 2009 by Staff WritersMoxDuo IR demonstrates fewer side effects than percocet
Life scientists acknowledged in Eureka Awards
19 August, 2009 by Tim DeanThe Australian Museum Eureka Prizes showcase research done by researchers in the life sciences.
HIV-1 genome revealed
06 August, 2009 by Tim DeanBig picture view of the virus's genome uncovers structures that affection function.
Esler awarded Victoria Prize
28 July, 2009 by Tim DeanBaker IDI's Professor Murray Esler awarded Victoria Prize for work in cardiovascular disease.
The performance of perforin-like proteins
14 July, 2009 by Kate McDonaldUnderstanding the role of the membrane attack complex/perforin-like protein (MACPF) super-family is the main aim of Professor James Whisstock’s lab. Recently, the lab has been able to help solve a scientific mystery dating back a hundred years.
Knocked down by a hairpin
13 July, 2009 by Fiona WylieRoss Dickins has been at the forefront of the revolution in gene knockdown using short hairpin RNAs. He’s using the technologies to attempt to achieve his dream – curing mice of the cancers he induces.
Heavy metal: the chemistry of Alzheimer’s disease
09 July, 2009 by Kate McDonaldThe literature is full of failed attempts to find good biomarkers in blood, and Barnham thinks he knows why.
Aussie researchers find chink in AML
07 July, 2009 by Staff WritersNovel antibody targets and eliminates human acute myeloid leukemic stem cells in preclinical models.
microRNAs role in CV disease
06 July, 2009 by Tim DeanNew research on microRNAs holds promise for diagnosing and treating diseases in blood vessels.
Handheld lab receives INNOVIC gong
03 July, 2009 by Tim DeanHandheld medical diagnostic system inventor, Micah Atkin, wins INNOVIC’s 2009 International Next Big Thing Award.
Pig breeding facility for xenotransplantation opens in NZ
02 July, 2009 by Tim DeanLiving Cell Technologies opens pig breeding facility ahead of xenotransplantation trials to treat type 1 diabetes.
Minicells defeat drug resistant cancer
29 June, 2009 by Tim DeanAustralian researchers find that interfering RNA delivered via bacterially-derived minicells can target and kill drug resistant tumours.
Diabetes biomarker discovered
24 June, 2009 by Staff WritersHormone adiponectin could be used to better diagnose and treat type 2 diabetes.
Xenotransplantation trial to commence in NZ
24 June, 2009 by Tim DeanCalls for Australian Government to lift moratorium on xenotransplantation so similar trials can occur here.
